Intellectual Property - March 14, 2017
InDex Pharmaceuticals granted patent in the US
InDex Pharmaceuticals Holding announces that a patent covering 19 compounds from the company’s DIMS platform has been granted by the United States Patent and Trademark Office (USPTO). InDex has a discovery stage portfolio of more than 150 DNA-based ImmunoModulatory Sequences (DIMS), several of which are already protected by approved composition-of-matter patents. The new US patent, […]
Intellectual Property - March 2, 2017
Orexo enters patent infringement litigation against Actavis
Orexo has filed a patent infringement action in United States District Court for the District of Delaware against Actavis Elizabeth LLC, Actavis Pharma, Inc., and their parent company Teva. Orexo alleges that Actavis’s generic versions of Suboxone and Subutex tablets infringe Orexo’s US Patent No. 8,454,996 (the ‘996 patent). On November 15, 2016, the Delaware […]
Intellectual Property - February 8, 2017
Idogen reaches formal granting of patent in Japan
Idogen has announced that the Japan Patent Office (“JPO”) has granted the company’s patent application. The patent provides Idogen’s vaccine technology with a broad protection and further strengthens the company’s patent portfolio in an important market. The Japan Patent Office has now formally granted Idogen’s Patent Application covering induction of IDO for treatment of autoimmune […]
Intellectual Property - January 24, 2017
EU patent court to open in December
The new Europe’s Unified Patent Court, partly based in London, is expected to open in December this year. The UPC Preparatory Committee has said that it is working ‘under the assumption’ that the court will become operational before the end of year – with a targeted opening date of 1 December, reports the law society […]
Intellectual Property - January 13, 2017
The EPO intends to grant Idogen’s patent application
Idogen announces that the European Patent Office (EPO) has issued a Notice of Intention to Grant, which means that the patent office intends to grant Idogen’s patent application, covering the company’s tolerogenic vaccine technology. A related patent application received a Notice of Allowance in Japan in December 2016. The patent, and its validation in key […]
Intellectual Property - November 25, 2016
Kimberlie Cerrone – An IP strategist and a digital health entrepreneur
Often the greatest value of a company is not its buildings and equipment but its plans and creations. A firm’s intellectual property (IP) – its collective ideas, inventions and brainpower – is not always easily measured and often overlooked. Safeguarding it and maximizing its potential can give businesses – especially those in the life science […]
